Note 3 - Net Income (Loss) Per Common Share - Basic and Diluted - Schedule of Common Stock Equivalents Outstanding (Details) - shares |
Jun. 30, 2025 |
Dec. 31, 2024 |
Jun. 30, 2024 |
|---|---|---|---|
| Stock options (in shares) | 26,662,500 | 26,087,500 | 27,862,500 |
| Common Stock, Other Shares, Outstanding | 70,292,500 | 73,742,500 | |
| Series C Preferred Stock [Member] | |||
| Shares of Series C Preferred Stock (in shares) | 40,630,000 | 40,630,000 | |
| Restricted Stock Units (RSUs) [Member] | |||
| Restricted Stock Units (in shares) | 3,000,000 | 5,250,000 | 5,250,000 |
| X | ||||||||||
- Definition Number of shares of other common stock instruments held by shareholder, including, but not limited to, exchangeable shares. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued for each share of convertible preferred stock that is converted. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|